Gene Biotherapeutics, Inc. Notes Payable, Current
Gene Biotherapeutics, Inc. had Notes Payable, Current of $563.23 thousand as of 2020-12-31, per its 10-K/A filed 2022-04-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2022-04-14
- 2020-12-31: Notes Payable, Current $563.23K.
- 2020-09-30: Notes Payable, Current $551.45K.
- 2020-06-30: Notes Payable, Current $290.20K.
- 2020-03-31: Notes Payable, Current $281.98K.
| Period end | Notes Payable, Current |
|---|---|
| 2020-12-31 | $563.23K 10-K/A · filed 2022-04-14 |
| 2020-09-30 | $551.45K 10-Q · filed 2021-10-27 |
| 2020-06-30 | $290.20K 10-Q · filed 2021-09-17 |
| 2020-03-31 | $281.98K 10-Q · filed 2021-09-03 |
| 2019-12-31 | $273.75K 10-K/A · filed 2022-04-14 |
| 2018-12-31 | $240.75K 10-K · filed 2021-04-23 |
| 2017-12-31 | $211.50K 10-K · filed 2021-04-23 |
| 2016-06-30 | $30.00K 10-Q · filed 2017-03-06 |